Inno-Gene SA
WSE:IGN
Inno-Gene SA
Inventory
Inno-Gene SA
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inno-Gene SA
WSE:IGN
|
Inventory
zł14k
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-30%
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
Inventory
zł181k
|
CAGR 3-Years
43%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Inventory
zł1.6k
|
CAGR 3-Years
-86%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
N/A
|
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Inventory
zł615k
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
S
|
Selvita SA
WSE:SLV
|
Inventory
zł8.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Inno-Gene SA
Glance View
Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
See Also
What is Inno-Gene SA's Inventory?
Inventory
14k
PLN
Based on the financial report for Jun 30, 2024, Inno-Gene SA's Inventory amounts to 14k PLN.
What is Inno-Gene SA's Inventory growth rate?
Inventory CAGR 10Y
-30%
Over the last year, the Inventory growth was -99%. The average annual Inventory growth rates for Inno-Gene SA have been -77% over the past three years , -15% over the past five years , and -30% over the past ten years .
